Untersuchung des genetischen Schadens in peripheren ...

6 Literatur
RiedeU. N., Wiestler O. D., Müller H. J. Allgemeine und spezielle Pathologie,
4.Auflage; Thieme-Verl. (1995);
Benner E. S., Wargovich M. J., Lippman S. M., Hong W. K. (1993) Micronuclei:
a potential intermediate marker for chemoprevention of aerodigestive tract cancer.
Jou. Cell. Biochemi. Suppl. 17F, 250-254.
Brenner B. M., Cooper M. E., Zeeuw Dd. D., Grunfeld J.P., Keane W. F., Kurokawa K.,
McGill J. B., Mitch W. E., Parving H. H., Remuzzi G., Ribei A. B., Schluchter M. D.,
Snavely D., Zhang Z., Simps R., Shahinar S., RENAAL-Study Investigators (2000)
The Losartan renal protection study – rationale, study design and baseline
characteristics of RENAAL (Reduction of Endpoints in NIDDM with the Angiotensin II
Antagonist Losartan). J Renin Angiotensin Aldosterone Syst. 1(4), 328-335.
Eastmond D. A. and Tucker J. D. (1989) Identification of aneuploidy-inducing agents
using cytokinesis-blocked human lymphocytes and an antikinetochochore antibody.
Env. Mol. Mutagenesis 13, 34-43.
Eckert I. (1996) Mikrokerne: Entstehungsmechanismen und Bedeutung als Endpunkt
für Gentoxizität. Dissertationsschrift zur Erlangung des naturwissenschaftlichen
Doktorgrades der Bayerischen Julius-Maximilians-Universität Würzburg.
Fenech M. (1993) The cytogenesis-block micronucleus technique: a detailed description
of the method and its application to genotoxicity studies in human populations.
Mut. Res. 285, 35-44.
Fenech M. (1998) Important variables that influence base-line micronucleus frequency
in cytogenesis-blocked lymphocytes – a biomarker for DNA damage in human
populations. Mut. Res. 404, 155-165.
87